All Stories

  1. Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries
  2. Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved?
  3. Eosinophilic giant cell arteritis: A different subset of disease?
  4. Cardiovascular risk and access to primary care: Comparisons among Chinese documented and undocumented immigrants
  5. Comment on: Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study. Reply
  6. Accuracy of World Health Organisation‐grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study
  7. Comparing accuracy of tomosynthesis plus digital mammography or synthetic 2D mammography in breast cancer screening: baseline results of the MAITA RCT consortium
  8. Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: The four-way decomposition analysis
  9. CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infection
  10. European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening—a nested case-control study
  11. Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study
  12. A cohort study on the biochemical and haematological parameters of Italian blood donors as possible risk factors of COVID-19 infection and severe disease in the pre- and post-Omicron period
  13. Recruitment strategies and interventions to increase participation in lung cancer screening programmes: a systematic review protocol
  14. Motivation, acceptability and attitudes toward lung cancer screening among persons who attend a tobacco cessation program: A multicenter survey in Italy
  15. SARS-CoV-2 transmission patterns in educational settings during the Alpha wave in Reggio-Emilia, Italy
  16. High temperature, COVID-19, and mortality excess in the 2022 summer: a cohort study on data from Italian surveillances
  17. Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: a matched cross-sectional study
  18. Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
  19. Excluding specificity from research and development priorities is delaying the AI adoption in breast cancer screening
  20. Elements Characterising Multicomponent Interventions Used to Improve Disease Management Models and Clinical Pathways in Acute and Chronic Heart Failure: A Scoping Review
  21. Study of the impact of the procedure and donor features on plasma donation
  22. Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries
  23. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases
  24. The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15–16 years in Italy
  25. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022
  26. Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: the four-way decomposition analysis
  27. The effect of diabetes on COVID-19 incidence and mortality: Differences between highly-developed-country and high-migratory-pressure-country populations
  28. Residential exposure to air pollution and adverse respiratory and allergic outcomes in children and adolescents living in a chipboard industrial area of Northern Italy
  29. Activities Carried Out during the First COVID-19 Lockdown by Italian Citizens
  30. HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions
  31. The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: Results from national cross-sectional repeated surveys in 2020
  32. The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development
  33. Abdominal Fat Characteristics and Mortality in Rectal Cancer: A Retrospective Study
  34. Association between short-term exposure to air pollutants and cause-specific daily mortality in Italy. A nationwide analysis
  35. Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data
  36. Heat wave, COVID-19, and mortality excess in the 2022 summer: a cohort study on data from Italian surveillances
  37. Surveillance, contact tracing and characteristics of SARS-CoV-2 transmission in educational settings in Northern Italy, September 2020 to April 2021
  38. Effectiveness of mobile health interventions targeting parents to prevent and treat childhood Obesity: Systematic review
  39. Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study
  40. The epidemiology of oral cancer during the COVID-19 pandemic in Northern Italy: Incidence, survival, prevalence
  41. Modifications of Chest CT Body Composition Parameters at Three and Six Months after Severe COVID-19 Pneumonia: A Retrospective Cohort Study
  42. What a woman needs to know about overdiagnosis to decide about breast cancer screening
  43. Diabetes and COVID-19 testing, positivity, and mortality: A population-wide study in Northern Italy
  44. Exhaled breath condensate proteomic signatures potentially distinguish adenocarcinoma from benign cystic lesions of the pancreas
  45. The impact of the Covid-19 pandemic on Italian population-based cancer screening activities and test coverage: results from national cross-sectional repeated surveys
  46. A COVID-19-Dedicated Facility for the Care of Older Adults During a Health Emergency: An Italian Experience
  47. A deep learning approach for Spatio-Temporal forecasting of new cases and new hospital admissions of COVID-19 spread in Reggio Emilia, Northern Italy
  48. Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission
  49. Patient-centred care with self-compression mammography in clinical practice: a randomized trial compared to standard compression
  50. Validation of the Italian version of the Tool to Measure Parenting Self‐Efficacy questionnaire using data from an intervention study
  51. Incidence and Characteristics of Adverse Events after COVID-19 Vaccination in a Population-Based Programme
  52. Specific miRNAs Change After 3 Months of GH treatment and Contribute to Explain the Growth Response After 12 Months
  53. Prompt Resumption of Screening Programme Reduced the Impact of COVID-19 on New Breast Cancer Diagnoses in Northern Italy
  54. Imaging-based indices combining disease severity and time from disease onset to predict COVID-19 mortality: A cohort study
  55. Quality appraisal of documents producing recommendations for breast, colorectal and cervical cancer screening
  56. Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial
  57. Impact of Insulin Therapies on Cancer Incidence in Type 1 and Type 2 Diabetes: A Population-Based Cohort Study in Reggio Emilia, Italy
  58. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial
  59. A Randomized Trial Comparing Breast Cancer Incidence and Interval Cancers after Tomosynthesis Plus Mammography versus Mammography Alone
  60. Fusion radiology in interventional endoscopy (FRIend): a new approach for pancreatic fluid collections
  61. Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network–McMaster Guideline Development Checklist
  62. Clinical Epidemiology of Microinvasive Cervical Carcinoma in an Italian Population Targeted by a Screening Programme
  63. How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study
  64. Clinical and imaging characteristics of patients with COVID-19 predicting hospital readmission after emergency department discharge: a single-centre cohort study in Italy
  65. Adaptation of the Core Set for Vocational Rehabilitation for Cancer Survivors: A Qualitative Consensus-Based Study
  66. Return to work of Italian cancer survivors: A focus on prognostic work-related factors
  67. Inflammatory burden and persistent CT lung abnormalities in COVID-19 patients
  68. The role of PET/CT in disease activity assessment in patients with large vessel vasculitis
  69. Impact of a Human Papillomavirus Vaccination Program within Organized Cervical Cancer Screening: Cohort Study
  70. Photodynamic therapy for superficial basal cell carcinomas: Clinical features of partial responses and recurrences
  71. The IARC Perspective on Cervical Cancer Screening
  72. Thyroidectomies in Italy: A Population-Based National Analysis from 2001 to 2018
  73. Abstract OT2-10-02: Mypebs: An international randomized study comparing personalized, risk-stratified to standard breast cancer screening in women aged 40-70
  74. Barriers to Accessing Primary Care and Appropriateness of Healthcare Among Immigrants in Italy
  75. A nationwide study of air pollution from particulate matter and daily hospitalizations for respiratory diseases in Italy
  76. The impact of COVID‐19 on new mesothelioma diagnoses in Italy
  77. Correction to: Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
  78. Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic
  79. Vessel inflammation and morphological changes in patients with large vessel vasculitis: a retrospective study
  80. General and COVID-19-Related Mortality by Pre-Existing Chronic Conditions and Care Setting during 2020 in Emilia-Romagna Region, Italy
  81. Exploring the evidence for the effectiveness of health interventions for COVID-19 targeting migrants: a systematic review protocol
  82. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
  83. A Population-Based Study of Cardiovascular Disease Mortality in Italian Cancer Patients
  84. The IARC Perspective on Cervical Cancer Screening
  85. Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population
  86. Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer
  87. A microscale hybrid modelling system to assess the air quality over a large portion of a large European city
  88. Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk
  89. Secondary transmission of SARS-CoV-2 in educational settings in Northern Italy from September 2020 to April 2021: a population-based study
  90. Five-year annual incidence and clinico-molecular features of breast cancer after the last negative screening mammography at age 68–69
  91. Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study
  92. Corrigendum to: p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
  93. Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study
  94. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study
  95. The impact of COVID‐19 outbreak on the Transfusion Medicine Unit of a Northern Italy Hospital and Cancer Centre
  96. Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3
  97. Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
  98. The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients
  99. Colon cancer survival differs from right side to left side and lymph node harvest number matter
  100. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room
  101. Beyond Lockdown: The Potential Side Effects of the SARS-CoV-2 Pandemic on Public Health
  102. The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis
  103. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study
  104. Cumulative COVID ‐19 incidence, mortality and prognosis in cancer survivors: A population‐based study in Reggio Emilia, Northern Italy
  105. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy
  106. Effectiveness of mobile health interventions targeting parents to prevent and treat childhood obesity: a systematic review (Preprint)
  107. Multicentre Evaluation of Hepika Test Clinical Accuracy in Diagnosing HPV-Induced Cancer and Precancerous Lesions of the Uterine Cervix
  108. GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature
  109. Impact of multidisciplinary approach and radiologic review on surgical outcome and overall survival of patients with pancreatic cancer: a retrospective cohort study
  110. Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients
  111. Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
  112. Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed
  113. Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer
  114. Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes
  115. Guideline-based quality assurance: a conceptual framework for the definition of key elements
  116. Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative
  117. The association between clinical laboratory data and chest CT findings explains disease severity in a large Italian cohort of COVID-19 patients
  118. Optimising plasmapheresis procedure: The role of plasma unit weight setting
  119. Using text analysis software to identify determinants of inappropriate clinical question reporting and diagnostic procedure referrals in Reggio Emilia, Italy
  120. Hepatitis C virus cascade of care in the general population, in people with diabetes, and in substance use disorder patients
  121. Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy
  122. Retrospective analysis of the effect on interval cancer rate of adding an artificial intelligence algorithm to the reading process for two-dimensional full-field digital mammography
  123. Poor Sleep during the First Peak of the SARS-CoV-2 Pandemic: A Cross-Sectional Study
  124. Are Individuals with Substance Use Disorders at Higher Risk of SARS-CoV-2 Infection? Population-Based Registry Study in Northern Italy
  125. Development of evidence-based guidelines for follow up of women treated for cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) in Italian screening programmes
  126. Systematic review of existing guidelines for NAFLD assessment
  127. Secondary transmission of COVID-19 in preschool and school settings in northern Italy after their reopening in September 2020: a population-based study
  128. Breast cancer screening: in the era of personalized medicine, age is just a number
  129. <p>Survival of Hospitalized COVID-19 Patients in Northern Italy: A Population-Based Cohort Study by the ITA-COVID-19 Network</p>
  130. Susceptibility to COVID‐19 in Patients Treated With Antimalarials: A Population‐Based Study in Emilia‐Romagna, Northern Italy
  131. Development and first application of an audit system for screening programs based on the PRECEDE-PROCEED model: an experience with breast cancer screening in the region of Lombardy (Italy)
  132. Cumulative COVID-19 incidence, mortality, and prognosis in cancer survivors: a population-based study in Reggio Emilia, Northern Italy
  133. Secondary transmission of COVID-19 in preschool and school settings after their reopening in northern Italy: a population-based study
  134. Facial palsy during the COVID‐19 pandemic
  135. Five-year relative survival by stage of breast and colon cancers in Italy
  136. Determinants of p16/Ki‐67 adequacy and positivity in HPV‐positive women from a screening population
  137. Knowledge, Opinion, and Attitude About the Italian Law on Advance Directives: A Population-Based Survey
  138. Recommendations from the European Commission Initiative on Breast Cancer on multigene tests to guide the use of adjuvant chemotherapy in patients who have hormone receptor positive, HER-2 negative, lymph node negative or up to 3 lymph nodes positive in...
  139. Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
  140. Evaluation of an intervention aimed at supporting new parents: the Baby Newsletter project
  141. Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy
  142. Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
  143. Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
  144. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study
  145. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
  146. Abdominal Visceral Infarction in 3 Patients with COVID-19
  147. Temporal profile and determinants of viral shedding and of viral clearance confirmation on nasopharyngeal swabs from SARS-CoV-2-positive subjects: a population-based prospective cohort study in Reggio Emilia, Italy.
  148. SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia
  149. Accuracy of CT in a cohort of symptomatic patients with suspected COVID-19 pneumonia during the outbreak peak in Italy
  150. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
  151. Response to: ‘COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study’ by Cuceoglu et al
  152. Case fatality rate in patients with COVID-19 infection and its relationship with length of follow up
  153. Source-related components of fine particulate matter and risk of adverse birth outcomes in Northern Italy
  154. Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement
  155. Personalized early detection and prevention of breast cancer: ENVISION consensus statement
  156. Mowat-Wilson syndrome: growth charts
  157. Geographic Inequalities in Breast Cancer in Italy: Trend Analysis of Mortality and Risk Factors
  158. Describing the Process and Tools Adopted to Cocreate a Smartphone App for Obesity Prevention in Childhood: Mixed Method Study
  159. Development and use of health outcome descriptors: a guideline development case study
  160. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study
  161. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
  162. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study
  163. Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID19 Network
  164. Early life weight patterns and risk of obesity at 5 years: A population-based cohort study
  165. Risk of cancer in individuals with alcohol and drug use disorders: a registry-based study in Reggio Emilia, Italy
  166. Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy
  167. Association between Urinary Levels of Aflatoxin and Consumption of Food Linked to Maize or Cow Milk or Dairy Products
  168. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high‐risk human papillomavirus at primary screening
  169. New information flows for cancer registries: testing the use of laboratory data in the province of Reggio Emilia, Italy
  170. Epidemiology and biological characteristics of male breast cancer in Italy
  171. HPV screening performance indicators in women who previously tested HPV-negative: The second round of Vallecamonica screening programme, Northern Italy
  172. Interlaboratory concordance of p16/Ki‐67 dual‐staining interpretation in HPV‐positive women in a screening population
  173. Optimization and validation of a LC-HRMS method for aflatoxins determination in urine samples
  174. Temporal Profile and Determinants of Viral Shedding and of Viral Clearance Confirmation on Nasopharyngeal Swabs from SARS-CoV-2-Positive Subjects: A Population-Based Study in Reggio Emilia
  175. A cluster randomized trial to measure the impact on nonsteroidal anti-inflammatory drug and proton pump inhibitor prescribing in Italy of distributing cost-free paracetamol to osteoarthritic patients
  176. Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
  177. Changes in the incidence of cervical tumours by disease stage in a cytology-based screening programme
  178. Risk of CIN2 or more severe lesions after negative HPV‐mRNA E6/E7 overexpression assay and after negative HPV‐DNA test: Concurrent cohorts with a 5‐year follow‐up
  179. Neoadjuvant therapy for breast cancer
  180. Describing the Process and Tools Adopted to Cocreate a Smartphone App for Obesity Prevention in Childhood: Mixed Method Study (Preprint)
  181. Corrigendum to “Associations between cervical, breast and colorectal cancer screening uptake, chronic diseases and health-related behaviours: Data from the Italian PASSI nationwide surveillance” [Prev. Med. 120 (2019) 60–70]
  182. The effect of Public Health/Pediatric Obesity interventions on socioeconomic inequalities in childhood obesity: A scoping review
  183. Five‐year risk of CIN3 after short‐term HPV‐DNA negativity in cytology‐negative women: a population‐based cohort study
  184. Correction: Determinants of inappropriate setting allocation in the care of patients with type 2 diabetes: A population-based study in Reggio Emilia province
  185. Methods for Development of the European Commission Initiative on Breast Cancer Guidelines
  186. Determinants of inappropriate setting allocation in the care of patients with type 2 diabetes: A population-based study in Reggio Emilia province
  187. Re: Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial
  188. Biomonitoring Data for Assessing Aflatoxins and Ochratoxin A Exposure by Italian Feedstuffs Workers
  189. Factors influencing return to work of cancer survivors: a population-based study in Italy
  190. Accuracy of imaging methods for steatohepatitis diagnosis in non‐alcoholic fatty liver disease patients: A systematic review
  191. CFTR and FOXO1 gene expression are reduced and high mobility group box 1 (HMGB1) is increased in the ovaries and serum of women with polycystic ovarian syndrome
  192. HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
  193. Comment on Cheng et al. Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988–2015. Diabetes Care 2018;41:2306–2315
  194. Annual mammography at age 45–49 years and biennial mammography at age 50–69 years: comparing performance measures in an organised screening setting
  195. Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis
  196. Associations between cervical, breast and colorectal cancer screening uptake, chronic diseases and health-related behaviours: Data from the Italian PASSI nationwide surveillance
  197. Comparing two visualization protocols for tomosynthesis in screening: specificity and sensitivity of slabs versus planes plus slabs
  198. Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study
  199. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer
  200. Estimating the impact of an organised screening programme on cervical cancer incidence: A 26‐year study from northern Italy
  201. Survival predictors in biopsy-proven giant cell arteritis: a northern Italian population-based study
  202. Evidence-based screening protocols for cervical cancer?
  203. The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
  204. The impact of blind peer review (team reading) of equivocal/abnormal Papanicolaou smears on inter-reader agreement
  205. Molecular imaging biomarkers for breast cancer risk and personalized screening
  206. Cancer incidence following long-term consumption of drinking water with high inorganic selenium content
  207. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study
  208. Geographical and socioeconomic differences in uptake of Pap test and mammography in Italy: results from the National Health Interview Survey
  209. Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study
  210. Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial
  211. Cohort profile: the Italian Network of Longitudinal Metropolitan Studies (IN-LiMeS), a multicentre cohort for socioeconomic inequalities in health monitoring
  212. Effectiveness of integrated care model for type 2 diabetes: A population-based study in Reggio Emilia (Italy)
  213. Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing
  214. Human papilloma virus genotyping for the cross‐sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more
  215. Role of HPV DNA testing in modern gynaecological practice
  216. Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy
  217. Association between mothers’ screening uptake and daughters’ HPV vaccination: a quasi-experimental study on the effect of an active invitation campaign
  218. Socioeconomic deprivation worsens the outcomes of Italian women with hormone receptor-positive breast cancer and decreases the possibility of receiving standard care
  219. Factors Influencing the Accuracy of Infectious Disease Reporting in Migrants: A Scoping Review
  220. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes
  221. Lifestyle-tailored interventions for South Asians with type 2 diabetes living in high-income countries: a systematic review
  222. Digital breast tomosynthesis (DBT): recommendations from the Italian College of Breast Radiologists (ICBR) by the Italian Society of Medical Radiology (SIRM) and the Italian Group for Mammography Screening (GISMa)
  223. Mammography screening: please don't be vague, tell me when I should come!
  224. Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference
  225. Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy
  226. Effects of the Addition of a Dual Task to a Supervised Physical Exercise Program on Older Adults’ Cognitive Performance
  227. Survey on Urinary Levels of Aflatoxins in Professionally Exposed Workers
  228. Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature
  229. Efficacy of self-sampling in promoting participation to cervical cancer screening also in subsequent round
  230. Changes in Mortality and Incidence of Prostate Cancer by Risk Class in Different Periods in Italy: The Possible Effects of PSA Spread
  231. Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy
  232. Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy
  233. Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types
  234. Trends in net survival from kidney cancer in six European Latin countries
  235. Sex Differences in the Effect of Type 2 Diabetes on Major Cardiovascular Diseases: Results from a Population-Based Study in Italy
  236. Interobserver reproducibility of cytologic p16INK4a/Ki-67 dual immunostaining in human papillomavirus-positive women
  237. Cognitive Clusters in Specific Learning Disorder
  238. Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study
  239. Impact of variations in triage cytology interpretation on human papillomavirus–based cervical screening and implications for screening algorithms
  240. Prevalence of Primary HPV in Djibouti
  241. Long-term mortality patterns in a residential cohort exposed to inorganic selenium in drinking water
  242. Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy
  243. Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program
  244. Cervical cancer screening in immigrant women in Italy
  245. Differences in mortality by immigrant status in Italy. Results of the Italian Network of Longitudinal Metropolitan Studies
  246. Diagnostic values of glycated haemoglobin and diagnosis of diabetes: Results of a cross-sectional survey among general practitioners in the province of Reggio Emilia, Italy
  247. Recommendation without experts? Epistemological implications in the development of screening guidelines
  248. Comment on “Incidence of Type 1 Diabetes among Children and Adolescents in Italy between 2009 and 2013: The Role of a Regional Childhood Diabetes Registry”
  249. Team Reading (Peer Review) of Suspicious/Positive Slides for Continuous Quality Improvement in Cervical-Vaginal Cytology: A Comparison between Methods and Indicators
  250. Use of Cytology, E6/E7 mRNA, and p16INK4a–Ki-67 to Define the Management of Human Papillomavirus (HPV)–Positive Women in Cervical Cancer Screening
  251. Comparative cyclic tests of exterior flat slab–column connections in normal concrete and fiber-reinforced lightweight aggregate concrete
  252. Motivational Interviewing to Treat Overweight Children: 24-Month Follow-Up of a Randomized Controlled Trial
  253. Letter to the editor: Responding to a call for action - where are we now?
  254. Colorectal cancer screening of immigrants to Italy. Figures from the 2013 National Survey
  255. Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study
  256. Impact of the Introduction of Digital Mammography in an Organized Screening Program on the Recall and Detection Rate
  257. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study
  258. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
  259. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5
  260. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5
  261. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study
  262. The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods
  263. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5
  264. Towards a European Framework to Monitor Infectious Diseases among Migrant Populations: Design and Applicability
  265. Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion
  266. Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy
  267. Cervical Cancer Screening by Human Papillomavirus Testing Followed by Cytology Triage
  268. Changes in cervical cancer incidence following the introduction of organized screening in Italy
  269. HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs
  270. Cervical cancer epidemiology in foreign women in Northern Italy
  271. Exposure to emissions from municipal solid waste incinerators and miscarriages: A multisite study of the MONITER Project
  272. Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter
  273. Screening history of cervical cancers in Emilia-Romagna, Italy
  274. Differences in diabetes prevalence and inequalities in disease management and glycaemic control by immigrant status: a population-based study (Italy)
  275. Corrigendum to “A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomized controlled trial in population-based screening programmes” [Prev. Med. 65 (2014) 70–76]
  276. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter
  277. Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
  278. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
  279. Sex Differences in Cardiovascular Mortality in Diabetics and Nondiabetic Subjects: A Population-Based Study (Italy)
  280. Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme
  281. Health care costs and functional outcomes of road traffic injuries in the Lazio region of Italy
  282. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes
  283. Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer
  284. Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients
  285. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence
  286. HPV-based screening for prevention of invasive cervical cancer – Authors' reply
  287. Screening: the information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening
  288. Impact of p16INK4a Immunohistochemistry Staining on Interobserver Agreement on the Diagnosis of Cervical Intraepithelial Neoplasia
  289. Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy
  290. Public and private pregnancy care in Reggio Emilia Province: an observational study on appropriateness of care and delivery outcomes
  291. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
  292. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
  293. The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs
  294. Building a population-based diabetes register: An Italian experience
  295. Occupational Exposure to Physical Agents: The New Italian Database for Risk Assessment and Control
  296. The use of Cincinnati prehospital stroke scale during telephone dispatch interview increases the accuracy in identifying stroke and transient ischemic attack symptoms
  297. Validation and improvement of N1 method for pushover analysis
  298. Effects of immigrant status on Emergency Room (ER) utilisation by children under age one: a population-based study in the province of Reggio Emilia (Italy)
  299. Pediatrician-led Motivational Interviewing to Treat Overweight Children: An RCT
  300. Triage of women with minor abnormal cervical cytology: Meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types
  301. Re: Lead time and down-staging in the survival of cervical cancer cases detected by screening
  302. Screening patterns within organized programs and survival of Italian women with invasive cervical cancer
  303. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: A follow-up study
  304. First results of a new methodology for the identification of road surface anomalies
  305. Clinical Impact of the Analytical Specificity of the Hybrid Capture 2 Test: Data from the New Technologies for Cervical Cancer (NTCC) Study
  306. How socioeconomic status influences road traffic injuries and home injuries in Rome
  307. Increased incidence of thyroid cancer in Latina, Italy: A possible role of detection of subclinical disease
  308. Key factors influencing lung cancer survival in northern Italy
  309. Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
  310. Methods to increase participation in organised screening programs: a systematic review
  311. The Present and Future of Cervical Cancer Screening Programmes in Europe
  312. Prognostic Value of HPV E6/E7 mRNA Assay in Women with Negative Colposcopy or CIN1 Histology Result: A Follow-Up Study
  313. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial
  314. Health Technology Assessment of Computer-Assisted Pap Test Screening in Italy
  315. Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer
  316. Weighted‐peak assessment of occupational exposure due to MRI gradient fields and movements in a nonhomogeneous static magnetic field
  317. How to increase uptake in oncologic screening: A systematic review of studies comparing population-based screening programs and spontaneous access
  318. Meta‐analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test
  319. Appropriateness of the Indication for Colonoscopy
  320. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study
  321. HPV Testing Is an Efficient Management Choice for Women With Inadequate Liquid-Based Cytology in Cervical Cancer Screening
  322. Consent for Research With Biological Samples: One-Time General Consent Versus a Gift Model
  323. Early and Mid-Term Clinical Outcome of Emergency PCI in Patients with STEMI due to Unprotected Left Main Coronary Artery Disease
  324. HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
  325. Menometrorrhagia in magnetic resonance imaging operators with copper intrauterine contraceptive devices (IUDS): A case report
  326. A case–control study on risk factors of domestic accidents in an elderly population
  327. Nitinol Stents With Polymer-Free Paclitaxel Coating for Lesions in the Superficial Femoral and Popliteal Arteries Above the Knee:Twelve-Month Safety and Effectiveness Results From the Zilver PTX Single-Arm Clinical Study
  328. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy
  329. HPV prevalence and accuracy of HPV testing to detect high‐grade cervical intraepithelial neoplasia
  330. Sensitivity, Specificity, and Clinical Value of Human Papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for Cervical Cytology and HPV DNA Test
  331. Occupational and environmental exposure to extremely low frequency-magnetic fields: a personal monitoring study in a large group of workers in Italy
  332. Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting
  333. HPV types in early-onset cervical cancer
  334. Distribution of high and low risk HPV types by cytological status: a population based study from Italy
  335. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)
  336. Exposure to magnetic fields of railway engine drivers: a case study in Italy
  337. Triage and Injury Severity Scores as predictors of mortality and hospital admission for injuries: A validation study
  338. Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy
  339. An integrated surveillance system of road traffic injuries in the Lazio region of Italy: results of a 5-year study (2001–2005)
  340. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study
  341. Tailored Screening for Breast Cancer in Premenopausal Women: Not Just Looking at Sensitivity, But Aiming to Reduce Burden
  342. HPV 16/18 vaccines and the impact on organized cervical cancer screening
  343. Efficacy of HPV 16/18 vaccines on sexually active young women and the impact on organized cervical cancer screening
  344. End-of-Life Care in Italian Hospitals: Quality of and Satisfaction With Care From the Caregivers' Point of View—Results from the Italian Survey of the Dying of Cancer
  345. Screening for Cervical Cancer with the Human Papillomavirus Test in an Area of Central Italy with No Previous Active Cytological Screening Programme
  346. Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy
  347. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
  348. Validity of caregiver-reported hospital admission in a study on the quality of care received by terminally ill cancer patients
  349. Mobile phones exposure induces changes of contingent negative variation in humans
  350. The Reproducibility of CIN Diagnoses Among Different Pathologists
  351. Validating regional Hospital Information System data through comparison with a local cancer register to identify interval cancers of a breast screening program
  352. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
  353. Incidence of bacterial meningitis (2001–2005) in Lazio, Italy: the results of a integrated surveillance system
  354. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy
  355. Health and economic impact associated with a quadrivalent HPV vaccine in Italy
  356. An emergency clinical pathway for stroke patients – results of a cluster randomised trial (isrctn41456865)
  357. The allergic sensitization in infants with atopic eczema from different countries
  358. Road traffic injuries in one local health unit in the Lazio region: results of a surveillance system integrating police and health data
  359. Exposure of Workers to Electromagnetic Fields. A Review of Open Questions on Exposure Assessment Techniques
  360. HPV vaccination and colposcopy workload of screening programmes
  361. New paradigms in cervical cancer prevention: opportunities and risks
  362. Re: Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
  363. Syndromic surveillance: sensitivity and positive predictive value of the case definitions
  364. Early atopic disease and early childhood immunization – is there a link?
  365. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
  366. Can colorectal cancer mass-screening organization be evidence-based? Lessons from failures: The experimental and pilot phases of the Lazio program
  367. Do women ⩾50 years of age need as much screening as women <50 years after they have had negative screening results?
  368. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women
  369. Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test
  370. Mortality in elderly injured patients: the role of comorbidities*
  371. No evidence of major transcriptional changes in the brain of mice exposed to 1800 MHz GSM signal
  372. The Risk of False-Positive Histology According to the Reason for Colposcopy Referral in Cervical Cancer Screening
  373. Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study
  374. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment
  375. The impact of new technologies in cervical cancer screening: Results of the recruitment phase of a large randomised controlled trial from a public health perspective
  376. Home injuries mortality: Sensitivity and specificity analysis of different data sources and operative definitions
  377. Dying of cancer in Italy: impact on family and caregiver. The Italian Survey of Dying of Cancer
  378. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial
  379. Agreement Between Emergency Room and Discharge Diagnoses in a Population of Injured Inpatients: Determinants and Mortality
  380. Inequity in the provision of and access to palliative care for cancer patients. Results from the Italian survey of the dying of cancer (ISDOC)
  381. Streptococcus pneumoniae incidence in western Europe – Authors' reply
  382. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology
  383. Evaluation of the health effects of the new driving penalty point system in the Lazio Region, Italy, 2001-4
  384. Cost-effectiveness of vaccinating for invasive pneumococcal disease in the elderly in the Lazio region of Italy
  385. Corrigendum to “Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy” [Prev. Med. 41 (2005) 30–35]
  386. Unintentional home injuries reported by an emergency-based surveillance system: Incidence, hospitalisation rate and mortality
  387. The effect of screening programmes on the treatment of benign breast neoplasms: observations from current practice in Italy
  388. Colorectal cancer screening: Recommendations and guideline adherence by physicians from digestive endoscopy centers in the Lazio region, Italy
  389. Defining a common set of indicators to monitor road accidents in the European Union
  390. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old
  391. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial
  392. Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
  393. Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC)
  394. Diagnosis and prognosis disclosure among cancer patients. Results from an Italian mortality follow-back survey
  395. Correspondence
  396. Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods
  397. The Role of GPs in Increasing Compliance to Colorectal Cancer Screening: A Randomised Controlled Trial (Italy)
  398. Is the type of test used for mass colorectal cancer screening a determinant of compliance?
  399. Electromagnetic Fields: Principles of Exposure Mitigation
  400. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]
  401. The last three months of life of Italian cancer patients. Methods, sample characteristics and response rate of the Italian Survey of the Dying of Cancer (ISDOC)
  402. In Vitro Evaluation of Biological Effects on Human Keratinocytes Exposed to 900 MHz Electromagnetic Field
  403. A controversial necrotizing enterocolitis outbreak in a neonatal unit
  404. Does a pre-hospital emergency pathway improve early diagnosis and referral in suspected stroke patients? – Study protocol of a cluster randomised trial [ISRCTN41456865]
  405. Road Traffic Injuries in Lazio, Italy: A Descriptive Analysis From an Emergency Department–Based Surveillance System
  406. Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy
  407. Trying to improve the compliance to colorectal cancer screening: A complex study design for a complex planning question
  408. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial
  409. Choosing immunisation coverage indicators at the local level
  410. An epidemic of gastroenteritis and mild necrotizing enterocolitis in two neonatal units of a University Hospital in Rome, Italy
  411. Voltage-Operated Calcium Channel Heterogeneity in Pancreatic   Cells: Physiopathological Implications
  412. Outbreaks of food borne diseases in the Lazio region, Italy: The results of epidemiological field investigations
  413. Factors Associated with Hepatitis B Virus Immunization Coverage at the Beginning of a Population Campaign in the Lazio Region, Italy
  414. Timing of Gene Expression and Oolemma Localization of Mouse α6and β1Integrin Subunits during Oogenesis
  415. Meiotic and Developmental Competence of Mouse Antral Oocytes1
  416. Chromatin organization during mouse oocyte growth